Evidence map›Paper›PMID 29876151›Full record

ArticleCureus2018

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer.

Marieke J Van Son, Max Peters, Marinus A Moerland, Juus L Noteboom, Wietse S Eppinga, Raquel Davila Fajardo, Jan Lagendijk, Jochem R Van der Voort van Zyp

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marieke J Van SonDepartment of Radiation Oncology, University Medical Center Utrecht.
Max PetersDepartment of Radiation Oncology, University Medical Center Utrecht.
Marinus A MoerlandDepartment of Radiation Oncology, University Medical Center Utrecht.
Juus L NoteboomDepartment of Radiation Oncology, University Medical Center Utrecht.
Wietse S EppingaDepartment of Radiation Oncology, University Medical Center Utrecht.
Raquel Davila FajardoDepartment of Radiation Oncology, University Medical Center Utrecht.
Jan LagendijkDepartment of Radiotherapy, University Medical Center Utrecht.
Jochem R Van der Voort van ZypDepartment of Radiation Oncology, University Medical Center Utrecht.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer recurrences are common, even with twenty-first-century primary prostate cancer treatment modalities. The most common salvage treatment is (delayed) hormonal therapy, which is often associated with serious side-effects. Due to the risk of significant toxicity, whole-gland targeted salvage treatments remain unpopular. Consequently, developments in focal therapies have arisen. Magnetic resonance imaging (MRI)-guided focal salvage high-dose-rate brachytherapy (HDR-BT) is a novel treatment aiming for minimal toxicity in recurrent prostate cancer patients. Repeating focal treatment could, therefore, be possible in case of post-salvage recurrence. We report the case of a 77-year-old man who underwent repeat focal HDR-BT.

Indexed as

brachytherapyinterventional magnetic resonance imagingprostate cancerrecurrencesalvage therapy

Identifiers

PMID29876151
PMCPMC5988341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.